Advanced Medical Solutions Group (LON:AMS) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• Advanced Medical Solutions Group's stock price recently crossed above its 200-day moving average, closing at GBX 212 ($2.85) after a high of GBX 221 ($2.97).
• Research firms such as Berenberg Bank and Deutsche Bank have reiterated "buy" ratings for AMS, setting price targets of GBX 300 ($4.03) and GBX 275 ($3.70), respectively.
• Insider transactions showed significant selling, with 435,255 shares sold in the last quarter, valued at approximately $84.7 million.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 204.59 ($2.76) and traded as high as GBX 221 ($2.98). Advanced Medical Solutions Group shares last traded at GBX 212 ($2.86), with a volume of 1,215,682 shares traded.

Analyst Ratings Changes

Several research analysts have recently weighed in on AMS shares. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 275 ($3.71) target price on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Berenberg Bank reiterated a "buy" rating and issued a GBX 300 ($4.05) target price on shares of Advanced Medical Solutions Group in a research note on Tuesday, July 15th.

Advanced Medical Solutions Group Stock Down 1.7%

The business's fifty day moving average price is GBX 207.45 and its 200 day moving average price is GBX 204.41. The company has a market capitalization of £436.17 million, a P/E ratio of 39.14, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.